CN107436359A - Ferritin diagnostic kit - Google Patents

Ferritin diagnostic kit Download PDF

Info

Publication number
CN107436359A
CN107436359A CN201710613714.3A CN201710613714A CN107436359A CN 107436359 A CN107436359 A CN 107436359A CN 201710613714 A CN201710613714 A CN 201710613714A CN 107436359 A CN107436359 A CN 107436359A
Authority
CN
China
Prior art keywords
ferritin
monoclonal antibody
diagnostic kit
line
pad
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710613714.3A
Other languages
Chinese (zh)
Inventor
江斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710613714.3A priority Critical patent/CN107436359A/en
Publication of CN107436359A publication Critical patent/CN107436359A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard

Abstract

The present invention relates to medical treatment detection device technical field, and in particular to a kind of ferritin diagnostic kit;A kind of ferritin diagnostic kit of the present invention, include the Test paper and colorimetric card of ferritin;The Test paper includes collaurum plastic bottom board, is pasted with sample pad, the colloidal gold pad for the colloid gold particle that the Anti-ferritin monoclonal antibody of coating pairing marks, nitrocellulose filter, detection line T, nature controlling line C successively on the collaurum plastic bottom board;The nitrocellulose filter overlaps with colloidal gold pad, and the other end and the sample pad of the colloidal gold pad overlap;The nature controlling line is coated with sheep anti-mouse igg antibody, and the detection line is coated with Anti-ferritin monoclonal antibody;The colorimetric card is provided with 10ng/ml, 20ng/ml, 50ng/ml ratio colo(u)r streak;Ferritin Levels of the kit of the present invention suitable for external half-quantitative detection human serum, blood plasma and whole blood, it is functional, it is low available for clinical detection, testing cost;Kit is easy to operate.

Description

Ferritin diagnostic kit
Technical field
The present invention relates to medical treatment detection device technical field, and in particular to a kind of ferritin diagnostic kit.
Background technology
Serum ferritin abbreviation ferritin (serum ferritsn, SF), a kind of compound protein of iron content, ferritin It is present in each tissue and cell in vivo, especially in spleen, mucous membrane of small intestine, in liver and red marrow.Ferritin can preserve iron In hollow globular protein, prevent that endocellular liberation iron is excessive and produce illeffects while can be as the depots of iron Synthesized for hemoglobin:Acidic Ferritin then plays iron transfer, its alkaline ferritin and holds and has pass.Epidemiology survey It was found that the content of ferritin is that 33.9 ± 16.3ng/ml. women is 32.7 ± 16.4ng/m1 in normal male, but women exists The gestational period can be due to reducing during acute anemia, and acute and chronic liver damage even hepatocarcinoma patient then has notable rise.Therefore can Rapidly, sensitive, the accurate SFF values for detecting and tracking in serum, blood plasma and whole blood have higher clinical value.
Determination of Serum Ferritin method has a variety of at present, such as radio-immunity double antibody method, ELISA and chemiluminescence Method etc..But the characteristics of time-consuming, effort and consumption money be present in present detection method, or even the defects of testing result is not accurate enough.
The content of the invention
Time-consuming, effort be present for the existing Determination of Serum Ferritin method of solution and consume the technical problem of money in the present invention, there is provided A kind of ferritin diagnostic kit.
In order to solve the above technical problems, the technical solution adopted in the present invention is:A kind of ferritin diagnostic kit, including The Test paper and colorimetric card of ferritin;The Test paper includes collaurum plastic bottom board, in the collaurum plastic bottom board On be pasted with sample pad, the colloidal gold pad of colloid gold particle of Anti-ferritin monoclonal antibody mark of coating pairing, nitre successively Acid cellulose film;Detection line T, nature controlling line C are set on the nitrocellulose filter;The nitrocellulose filter and colloidal gold pad One end overlaps, and the other end and the sample pad of the colloidal gold pad overlap;The nature controlling line is coated with sheep anti-mouse igg antibody, described Detection line is coated with Anti-ferritin monoclonal antibody;The colorimetric card is provided with 10ng/ml, 20ng/ml, 50ng/ml colorimetric Line, it is described than colo(u)r streak by the different red segment of the depth.
Above-mentioned ferritin diagnostic kit detection method is as follows:
1)Detection kit and sample are placed on and balanced 2 hours at room temperature.
2)Extract 10 μ l serum or plasma sample, when sample is whole blood if draw 20 μ l, be added to 10 times of sample In product dilution, fully mix;
3)Then take 100 μ l dilute samples to be put into clean centrifuge tube with pipettor, test card is put into centrifuge tube 2-3 points Zhong Hou, take out test paper and keep flat, read result in 15 minutes, be compared with colorimetric card.
Compared with prior art the invention has the advantages that.
Ferritin Levels of the kit of the present invention suitable for external half-quantitative detection human serum, blood plasma and whole blood, property Can be good, available for clinical detection.Kit of the present invention does not need any special instruments and equipment, and testing cost is low;Kit is grasped Make easy, it is not necessary to which professional operates.
Embodiment
Below in conjunction with specific embodiment, the invention will be further described.
Embodiment 1
A kind of ferritin diagnostic kit, include the Test paper and colorimetric card of ferritin;The Test paper includes collaurum Plastic bottom board, it is pasted with sample pad, the Anti-ferritin monoclonal antibody of coating pairing successively on the collaurum plastic bottom board The colloidal gold pad of the colloid gold particle of mark, nitrocellulose filter;Detection line T, nature controlling line are set on the nitrocellulose filter C;One end of the nitrocellulose filter and colloidal gold pad overlaps, and the other end and the sample pad of the colloidal gold pad overlap;It is described Nature controlling line is coated with sheep anti-mouse igg antibody, and the detection line is coated with Anti-ferritin monoclonal antibody;The colorimetric card is provided with 10ng/ml, 20ng/ml, 50ng/ml ratio colo(u)r streak, it is described than colo(u)r streak by the different red segment of the depth.
The Anti-ferritin monoclonal antibody is made up of the first monoclonal antibody and second monoclonal antibody, and described first is single Clonal antibody by deposit number be CGMCC NO.10595 hybridoma cell strain secrete to obtain, the second monoclonal antibody by Deposit number is that CGMCC NO.10594 hybridoma cell strain is secreted to obtain.
Described detection line T 12mm apart from the edge of nitrocellulose filter.
Described nature controlling line C 7mm apart from the edge of nitrocellulose filter.
Described detection line T and nature controlling line C distances are 5mm.
Embodiment 2
A kind of ferritin diagnostic kit, include the Test paper and colorimetric card of ferritin;The Test paper includes collaurum Plastic bottom board, it is pasted with sample pad, the Anti-ferritin monoclonal antibody of coating pairing successively on the collaurum plastic bottom board The colloidal gold pad of the colloid gold particle of mark, nitrocellulose filter;Detection line T, nature controlling line are set on the nitrocellulose filter C;One end of the nitrocellulose filter and colloidal gold pad overlaps, and the other end and the sample pad of the colloidal gold pad overlap;It is described Nature controlling line is coated with sheep anti-mouse igg antibody, and the detection line is coated with Anti-ferritin monoclonal antibody;The colorimetric card is provided with 10ng/ml, 20ng/ml, 50ng/ml ratio colo(u)r streak, it is described than colo(u)r streak by the different red segment of the depth.
The Anti-ferritin monoclonal antibody is made up of the first monoclonal antibody and second monoclonal antibody, and described first is single Clonal antibody by deposit number be CGMCC NO.10595 hybridoma cell strain secrete to obtain, the second monoclonal antibody by Deposit number is that CGMCC NO.10594 hybridoma cell strain is secreted to obtain.
Described detection line T 15mm apart from the edge of nitrocellulose filter.
Described nature controlling line C 6mm apart from the edge of nitrocellulose filter.
Described detection line T and nature controlling line C distances are 9mm.
The explanation of assay
1. one nature controlling line of appearance(C)Or response line(T)Color intensity be less than or equal to colorimetric card 10ng/ml lines, explanation The Ferritin Levels of sample are less than 10ng/ml.T line colors compare between 10-50ng/ml and colorimetric card compares sxemiquantitative judgement As a result.T line colors are better than colorimetric card 50ng/ml red lines, illustrate that sample Ferritin Levels are higher than 50ng/ml.
2. detection sample Ferritin Levels are less than or equal to 20ng/ml, the possible iron deficiency of testee is prompted, more than 20ng/ Ferro element may be had no lack of in ml prompting testee's bodies.
3. occur without nature controlling line(C)Only there is a response line red line in red line, and experimental result is null result, Ying Chong Examination.
Contrasted using detection kit of the present invention and 300 parts of immunofluorescence results, testing result finds sharing 296 parts of samples Product are consistent, and uniformity is more than 0.98.Show that the kit prepared is functional, can be used for clinical detection.
The present invention can be summarized with others without prejudice to the concrete form of the spirit or essential characteristics of the present invention.Therefore, nothing By from the point of view of which point, the embodiment above of the invention can only all be considered the description of the invention and can not limit invention, Claims indicate the scope of the present invention, and above-mentioned explanation does not point out the scope of the present invention, therefore, with the present invention The suitable implication and scope of claims in any change, be all considered as being included within the scope of the claims.

Claims (5)

1. a kind of ferritin diagnostic kit, it is characterised in that Test paper and colorimetric card including ferritin;The detection examination Paper includes collaurum plastic bottom board, is pasted with sample pad, the iron-resistant egg of coating pairing successively on the collaurum plastic bottom board The colloidal gold pad of the colloid gold particle of white labeling of monoclonal antibody, nitrocellulose filter;Inspection is set on the nitrocellulose filter Survey line T, nature controlling line C;One end of the nitrocellulose filter and colloidal gold pad overlaps, the other end and sample of the colloidal gold pad Pad overlap joint;The nature controlling line is coated with sheep anti-mouse igg antibody, and the detection line is coated with Anti-ferritin monoclonal antibody;It is described Colorimetric card is provided with 10ng/ml, 20ng/ml, 50ng/ml ratio colo(u)r streak, it is described than colo(u)r streak by the different red segment of the depth.
2. ferritin diagnostic kit according to claim 1, it is characterised in that the Anti-ferritin monoclonal antibody by First monoclonal antibody and second monoclonal antibody composition, first monoclonal antibody is CGMCC by deposit number NO.10595 hybridoma cell strain is secreted to obtain, and the second monoclonal antibody is CGMCC NO.10594's by deposit number Hybridoma cell strain is secreted to obtain.
3. ferritin diagnostic kit according to claim 1, it is characterised in that described detection line T is fine apart from nitric acid Tie up the edge 3-15mm of plain film.
4. ferritin diagnostic kit according to claim 1, it is characterised in that described nature controlling line C is fine apart from nitric acid Tie up the edge 5-8mm of plain film.
5. ferritin diagnostic kit according to claim 1, it is characterised in that described detection line T and nature controlling line C Distance is 4-9mm.
CN201710613714.3A 2017-07-25 2017-07-25 Ferritin diagnostic kit Pending CN107436359A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710613714.3A CN107436359A (en) 2017-07-25 2017-07-25 Ferritin diagnostic kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710613714.3A CN107436359A (en) 2017-07-25 2017-07-25 Ferritin diagnostic kit

Publications (1)

Publication Number Publication Date
CN107436359A true CN107436359A (en) 2017-12-05

Family

ID=60461129

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710613714.3A Pending CN107436359A (en) 2017-07-25 2017-07-25 Ferritin diagnostic kit

Country Status (1)

Country Link
CN (1) CN107436359A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020016571A1 (en) * 2018-07-16 2020-01-23 Donnelly George Arthur Ferritin analysis via lateral flow immunoassay
CN113777322A (en) * 2021-09-06 2021-12-10 珠海科域生物工程股份有限公司 Fecal calprotectin detection kit and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN202614770U (en) * 2012-05-22 2012-12-19 北京易斯威特生物医学科技有限公司 Ferritin quantitative detection system
CN202631544U (en) * 2012-04-06 2012-12-26 天津中新科炬生物制药有限公司 External detection reagent box for quick semi-quantitative detection of ferritin concentration
CN105131111A (en) * 2015-07-30 2015-12-09 中国检验检疫科学研究院 Human lactoferrin monoclonal antibody pair
CN205608007U (en) * 2016-03-31 2016-09-28 珠海华澳生物科技有限公司 Ferritin detect reagent box

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN202631544U (en) * 2012-04-06 2012-12-26 天津中新科炬生物制药有限公司 External detection reagent box for quick semi-quantitative detection of ferritin concentration
CN202614770U (en) * 2012-05-22 2012-12-19 北京易斯威特生物医学科技有限公司 Ferritin quantitative detection system
CN105131111A (en) * 2015-07-30 2015-12-09 中国检验检疫科学研究院 Human lactoferrin monoclonal antibody pair
CN205608007U (en) * 2016-03-31 2016-09-28 珠海华澳生物科技有限公司 Ferritin detect reagent box

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张改平: "《免疫层析试纸快速检测技术》", 31 August 2015 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020016571A1 (en) * 2018-07-16 2020-01-23 Donnelly George Arthur Ferritin analysis via lateral flow immunoassay
GB2578944A (en) * 2018-07-16 2020-06-03 Arthur Donnelly George Analyser
CN113777322A (en) * 2021-09-06 2021-12-10 珠海科域生物工程股份有限公司 Fecal calprotectin detection kit and preparation method thereof

Similar Documents

Publication Publication Date Title
Aydin et al. Decreased saliva/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology
Kolundžić et al. Galectin-1 is part of human trophoblast invasion machinery-a functional study in vitro
CN103575894B (en) A kind of detection method of visible biological chip
CN104316685B (en) Diacetyl spermine detection kit and preparation method and application thereof
Sato et al. Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat
WO2008031288A1 (en) Pre-filled centrifugal column for detecting hepatocellular carcinoma-specific alpha-fetoprotein variant and test kit containing the column
CN101988926A (en) Sandwich ELISA quantitative detection method of Golgi protein GP73 and detection kit thereof
CN104614534A (en) Rapid chromatography detection card and kit for simultaneously determining lipoprotein-associated phospholipase A2 and C reactive protein in blood plasma
CN107436359A (en) Ferritin diagnostic kit
CN107192832A (en) A kind of immunochromatography reagent bar of fluorogenic quantitative detection AMH and preparation method thereof
Singer et al. SULF2, a heparan sulfate endosulfatase, is present in the blood of healthy individuals and increases in cirrhosis
Arnold et al. Presence of hepcidin-25 in biological fluids: bile, ascitic and pleural fluids
JP2023078232A (en) Evacuated blood collection tubes containing protease inhibitors for assessment of contact system activation
CN109212229A (en) A kind of magnetic microparticle chemiluminescence kit of quantitative detection Angiotensin II content and preparation method thereof
EP3422004B1 (en) Method for detecting carcinoembryonic fibronectin using immunochromatography
CN114252594B (en) Placenta growth factor detection kit and preparation method and application thereof
KR102076354B1 (en) A process for detection and optional quantification of an analyte
JPH0543357B2 (en)
CN105842464A (en) Device for jointly quantitatively detecting uNGAL (urinary Neutrophil Gelatinase Associated Lipocalin) and uCr (urinary Creatinine) based on up-converting phosphor technology and preparation method of device
US20020076738A1 (en) Method and kit for predicting cancer
Furukawa et al. The production of vascular endothelial growth factor and metalloproteinase via protease-activated receptor in human endometrial stromal cells
CN106501532B (en) It is a kind of for detecting the kit of gastrin 17
WO2016082445A1 (en) Application of peptidylarginine deiminase 2 in preparation of reagent for clinical diagnosis of tumors
CN109991053A (en) A kind of neuronspecific enolase calibration object and preparation method thereof
CN105137095B (en) The immunoassay kits of free thyroxine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20171205

RJ01 Rejection of invention patent application after publication